Product Information

BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.0219 per EA under NDC 24689078105. Its NADAC has been published 199 times since Mar 3, 2021.

BUSPIRONE HCL 5 MG TABLET

Buspirone Hydrochloride
$0.0219per EA

Strength

5 mg/1

Manufacturer

Apnar Pharma LP

NDC

24689078105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209696

On Market Since

6/17/2024

Price Statistics

The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 199 times since Mar 3, 2021, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0219 per EA
All-time high$0.0314 (Nov 16, 2022)
All-time low$0.0214 (Oct 22, 2025)
52-week high$0.0232
52-week low$0.0214
Median price$0.0268
Average price$0.0260
Largest weekly change+11.5% (Oct 19, 2022)
Weeks tracked199
Tracking sinceMar 3, 2021

Price History

1W

0.0%

1M

-0.8%

3M

+1.0%

6M

-1.1%

1Y

-5.6%

3Y

-20.9%

5Y

-21.3%

All

-19.4%

Generic Alternatives

The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Apnar Pharma LP, is $0.0219 per EA (NDC 24689078105), effective Jun 24, 2026.

How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 19.4%. It has been tracked across 199 weekly CMS publications since Mar 3, 2021.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?

Since Mar 3, 2021, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0214 (Oct 22, 2025) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0268 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?

9 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 5 MG TABLET, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 5 MG TABLET?

BUSPIRONE HCL 5 MG TABLET (NDC 24689078105) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.